Beamtree (formerly Pacific Knowledge Systems) is a health data analytics company based in Sydney, Australia. It works around the world to better capture, manage and leverage human expertise to improve performance and health outcomes. Tim Kelsey was appointed chief executive in December 2020. Mark Britnell was appointed chair of the Beamtree Global Impact Committee in August 2021. The company recorded a 20% year-on-year growth, and 15% increase in annual recurring revenue in August 2021.
| Attributes | Values |
|---|
| rdfs:label
| |
| rdfs:comment
| - Beamtree (formerly Pacific Knowledge Systems) is a health data analytics company based in Sydney, Australia. It works around the world to better capture, manage and leverage human expertise to improve performance and health outcomes. Tim Kelsey was appointed chief executive in December 2020. Mark Britnell was appointed chair of the Beamtree Global Impact Committee in August 2021. The company recorded a 20% year-on-year growth, and 15% increase in annual recurring revenue in August 2021. (en)
|
| dcterms:subject
| |
| Wikipage page ID
| |
| Wikipage revision ID
| |
| Link from a Wikipage to another Wikipage
| |
| sameAs
| |
| dbp:wikiPageUsesTemplate
| |
| has abstract
| - Beamtree (formerly Pacific Knowledge Systems) is a health data analytics company based in Sydney, Australia. It works around the world to better capture, manage and leverage human expertise to improve performance and health outcomes. Tim Kelsey was appointed chief executive in December 2020. Mark Britnell was appointed chair of the Beamtree Global Impact Committee in August 2021. The company recorded a 20% year-on-year growth, and 15% increase in annual recurring revenue in August 2021. An international division was launched in the UK in 2021. The company acquired Ainsoff Pty Ltd, a clinician-led healthcare analytics company and Potential (x) an Australian firm that provides comparative analytics to support improvements in care in 2021. Ainsoff's founders Dr Levi Bassin and Dr David Bell will join the company. It has a partnership with the University of Sydney to establish a global center of excellence in health data research. The company funds an Associate Professor of Clinical Informatics and Data Science at the University of Sydney. It formed a partnership with the Central Adelaide Local Health Network to implement the RISQ data quality product across the network of four hospitals. Likewise, it will also support clinical decision-making for pathology services and integrate the Ainsoff Index, which is used to detect deterioration in its early stage, into the electronic medical record. In March 2022 it set up contracts with four NHS hospital trusts in England to use its RippleDown decision support technology to help drive improvements in patient care. The combined annual revenue is about £300,000. It also has a five-year contract with Ampath for the RippleDown software which automates up to 90% of clinical interpretations. In October 2022 it entered into a partnership to roll out its AI data and decision support products in 450 public and private hospitals in the Kingdom of Saudi Arabia. This is intended to "improve the quality of hospital data and analytic insight through the audit and automation of clinical record classification." It also has a $1.45 million contract to support the data transformation of the country's public health services. (en)
|
| prov:wasDerivedFrom
| |
| page length (characters) of wiki page
| |
| foaf:isPrimaryTopicOf
| |
| is Link from a Wikipage to another Wikipage
of | |
| is foaf:primaryTopic
of | |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)